Shoreline Biosciences – (iPSC)-Derived Allogeneic Natural Killer (NK) and Macrophage Products
Kleanthis Xanthopoulos, co-founder, Chairman and CEO of Shoreline Biosciences, discusses the development of genetically engineered induced pluripote...
3308 articles
Kleanthis Xanthopoulos, co-founder, Chairman and CEO of Shoreline Biosciences, discusses the development of genetically engineered induced pluripote...
Lisa Johnson-Pratt, MD, Senior Vice President, Ionis Pharmaceuticals, discusses her involvement in causes related to people of color, STEM (Science, Tec...
Peter Cathcart, internal medicine specialist in Nashville, Tennessee discusses his experience using the NextGen ® Mobile app on his phone to access hom...
John McGrail, a Clinical Hypnotherapist and Self Improvement Expert discusses his book, The Synthesis Effect that aims to help people create health, wel...
Jay Spence, PhD, clinical psychologist and Chief Product Officer at Uprise Health discusses why it’s so vital for employers and health plans to offer ...
Boro Dropulic, PhD, MBA, co-founder and Executive Director of Caring Cross, a 501(c)(3) non-profit dedicated to accelerating the development of advanced...
Boro Dropulic, PhD, MBA, co-founder and Executive Director at Caring Cross, a 501(c)(3) non-profit dedicated to accelerating the development of advanc...
Eran Eden, PhD, Co-founder and CEO of MeMed discusses MeMed BV™, the first technology that will detect in 15 minutes at point of care if a patient has...
Kim Smith-Whitley, MD, Executive Vice President and Head of Research and Development at Global Blood Therapeutics (GBT), discusses sickle cell disease (...
Melissa Orshan-Spann, Ph.D, CEDS-S, Chief Clinical Officer at Monte Nido & Affiliates, a company that provides treatment for eating disorders, will toda...